PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

59 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Deschler, S.* et al.: Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD. J. Hepatol., DOI: 10.1016/j.jhep.2025.06.006 (2025)
2.
Jaeckel, E.* ; Friedman, S.L.* ; Hudecek, M.* & Protzer, U.: Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases. J. Hepatol., DOI: 10.1016/j.jhep.2025.06.007 (2025)
3.
Kwon, Y. et al.: Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease. J. Hepatol. 82, 18-27 (2025)
4.
Chen, K.* et al.: EMC10 modulates hepatic ER stress and steatosis in an isoform specific manner. J. Hepatol. 81, 479-491 (2024)
5.
Yin, K. et al.: Polyploidisation pleiotropically buffers ageing in hepatocytes. J. Hepatol. 81, 289-302 (2024)
6.
Kotsiliti, E.* et al.: Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling. J. Hepatol. 79, 296-313 (2023)
7.
Koob, D.* et al.: Copper accumulation in chronic cholestatic disease augments liver damage by impairment of mitochondrial function. J. Hepatol. 77, S602-S603 (2022)
8.
Sandforth, L. ; El-Agroudy, N.N. & Birkenfeld, A.L.: Is NAFLD a key driver of brain dysfunction? J. Hepatol. 78, e129-e130 (2022)
9.
Su, J. et al.: Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. J. Hepatol. 78:15 (2022)
10.
Quitt, O. et al.: T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice. J. Hepatol. 75, 1058-1071 (2021)
11.
Teng, Y.* et al.: Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection. J. Hepatol. 75, 1072-1082 (2021)
12.
Wing, P.A.* et al.: Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter. J. Hepatol. 75, 64-73 (2021)
13.
Yuan, S.* et al.: Translatomic profiling reveals novel self-restricting virus-host interactions during HBV infection. J. Hepatol. 75, 74-85 (2021)
14.
Lampl, S.* et al.: Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytes. J. Hepatol. 73, 1347-1359 (2020)
15.
Lucifora, J.* et al.: Two-dimensional-cultures of primary human hepatocytes allow efficient HBV infection: Old tricks still work! J. Hepatol. 73, 449-451 (2020)
16.
Namineni, S. et al.: A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control. J. Hepatol. 72, 960-975 (2020)
17.
Pietrocola, F.* ; Castoldi, F.* ; Zischka, H. & Kroemer, G.*: Extending the mode of action of triethylenetetramine (trientine): Autophagy besides copper chelation. J. Hepatol. 73, 970-972 (2020)
18.
Schwerbel, K.* et al.: Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation. J. Hepatol. 73, 771-782 (2020)
19.
Marbach-Breitrück, E.* et al.: Tick-tock hedgehog-mutual crosstalk with liver circadian clock promotes liver steatosis. J. Hepatol. 70, 1192-1202 (2019)
20.
Oberhardt, V.* et al.: Viral escape contributes to the failure of hepatitis D virus-specific CD8+T-cells and drives evolution of HDV. J. Hepatol. 70, E21-E21 (2019)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮